2734. Evaluation of Empiric Antimicrobial Therapy for End-Stage Liver Disease Patients at an Academic Medical Center

BACKGROUND: Patients with end-stage liver disease (ESLD) are prone to decompensation secondary to infections, with an increasing prevalence of multidrug-resistant organisms (MDROs). These patients often receive broad-spectrum antimicrobials prior to transplant, pre-disposing them to resistant pathog...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Annie, Kaip, Emily A, Quan, David, Doernberg, Sarah B, Jariwala, Ripal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679144/
http://dx.doi.org/10.1093/ofid/ofad500.2345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679144/
http://dx.doi.org/10.1093/ofid/ofad500.2345

Ejemplares similares